Yuichi Iwaki's most recent trade in Medicinova Inc was a trade of 100,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 210,000 | 210,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 235,125 | 235,125 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 302,500 | 302,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 09 Jul 2021 | 39,583 | 966,933 (2%) | 0% | 2.5 | 100,541 | Common Stock |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 39,583 | 0 | - | - | Employee Stock option (Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 86,250 | 0 | - | - | Employee Stock option(Right to Buy) | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.46 per share. | 25 Feb 2021 | 86,250 | 927,350 (2%) | 0% | 2.5 | 212,175 | Common Stock |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 495,000 | 495,000 | - | - | Employee Stock Option (Right to Buy) |